Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary End Points

20250 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov Identifier: NCT02319837.

Published in: The Journal of Urology

Volume 215, Issue 4, pp. 396-407

Field-Weighted Citation Impact: 0.00